Press Release
Date
September 17, 2026

Will Epygen’s biosimilars bets pay off?

September 17, 2026

Epygen’s Participation in Global G20 Charter for Clean Energy

December 27, 2024

EPYGEN LISTED AMONGST TOP 10 NAMES IN BIOPHARMA

August 9, 2022

GOI funds Epygen Biotech to make affordable COVID-19 vaccine for less than Rs. 150 against old and new variants

August 9, 2022

Epygen Biotech Gets Funding From Govt For New Affordable Covid Vaccine

August 9, 2022

Epygen Biotech Announces Funding from India Government for Development of a COVID-19 Vaccine Using Dyadic’s Licensed C1 Protein Production Platform

August 9, 2022

Epygen Biotech and Dyadic advance low-cost COVID-19 vaccine candidate

June 20, 2022

Epygen Biotech Announces Funding from India Government for Development of a COVID-19 Vaccine Using Dyadic’s Licensed C1 Protein Production Platform

June 20, 2022

Epygen Biotech Announces Funding from India Government for Development of a COVID-19 Vaccine Using Dyadic’s Licensed C1

June 4, 2022

DBT-BACKED EPYGEN TO START TRIALS ON COVID VACCINE BELOW ₹150 A SHOT